Right ventriculoarterial coupling surrogates and long-term survival in LVAD recipients: Results of the ASSIST-ICD multicentric registry.

LVAD heart failure imaging prognosis ventriculoarterial coupling

Journal

Journal of cardiac failure
ISSN: 1532-8414
Titre abrégé: J Card Fail
Pays: United States
ID NLM: 9442138

Informations de publication

Date de publication:
06 Jun 2024
Historique:
received: 30 11 2023
revised: 09 04 2024
accepted: 10 05 2024
medline: 9 6 2024
pubmed: 9 6 2024
entrez: 8 6 2024
Statut: aheadofprint

Résumé

Prediction of outcomes remains an unmet need in LVAD candidates. Development of right heart failure portends an excess in mortality but imaging parameters of right ventricular systolic function have failed to demonstrate a prognostic role. By integrating pulmonary pressure, right ventriculoarterial coupling could fill this gap. The ASSIST-ICD registry was used to test right ventriculoarterial coupling surrogate parameters at implantation for the prediction of all-cause mortality. The ratio of the tricuspid annular plane systolic excursion over the estimated systolic pulmonary pressure (TAPSE/sPAP) was not associated with long-term survival in univariate analysis (p = 0.89), neither was the pulmonary artery pulsatility index (PAPi) (p = 0.13). Conversely, the ratio of the right atrial pressure over the pulmonary capillary wedge pressure (RAP/PCWP) was associated with all-cause mortality (p <0.01). After taking tricuspid regurgitation severity, LVAD indication, LVAD model, age, blood urea nitrogen, and pulmonary vascular resistance into account, RAP/PCWP remained associated with survival (HR 1.35 [1.10 - 1.65], p <0.01). Among pre-implant RVAC surrogates, only RAP/PCWP was associated with long-term all-cause mortality in LVAD recipients. This association was independent of established risk factors.

Sections du résumé

BACKGROUND BACKGROUND
Prediction of outcomes remains an unmet need in LVAD candidates. Development of right heart failure portends an excess in mortality but imaging parameters of right ventricular systolic function have failed to demonstrate a prognostic role. By integrating pulmonary pressure, right ventriculoarterial coupling could fill this gap.
METHODS METHODS
The ASSIST-ICD registry was used to test right ventriculoarterial coupling surrogate parameters at implantation for the prediction of all-cause mortality.
RESULTS RESULTS
The ratio of the tricuspid annular plane systolic excursion over the estimated systolic pulmonary pressure (TAPSE/sPAP) was not associated with long-term survival in univariate analysis (p = 0.89), neither was the pulmonary artery pulsatility index (PAPi) (p = 0.13). Conversely, the ratio of the right atrial pressure over the pulmonary capillary wedge pressure (RAP/PCWP) was associated with all-cause mortality (p <0.01). After taking tricuspid regurgitation severity, LVAD indication, LVAD model, age, blood urea nitrogen, and pulmonary vascular resistance into account, RAP/PCWP remained associated with survival (HR 1.35 [1.10 - 1.65], p <0.01).
CONCLUSION CONCLUSIONS
Among pre-implant RVAC surrogates, only RAP/PCWP was associated with long-term all-cause mortality in LVAD recipients. This association was independent of established risk factors.

Identifiants

pubmed: 38851449
pii: S1071-9164(24)00195-7
doi: 10.1016/j.cardfail.2024.05.007
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest None.

Auteurs

Maxime Beneyto (M)

Cardiology Department, Toulouse University Hospital, Toulouse, France. Electronic address: beneyto.maxime@gmail.com.

Raphaël Martins (R)

Cardiology Department, Rennes University Hospital, Rennes, France.

Vincent Galand (V)

Cardiology Department, Rennes University Hospital, Rennes, France.

Michel Kindo (M)

Strasbourg University Hospital, Strasbourg, France.

Clément Schneider (C)

Strasbourg University Hospital, Strasbourg, France.

Alexandre Sebestyen (A)

Grenoble University Hospital, La Tronche, France.

Aude Boignard (A)

Grenoble University Hospital, La Tronche, France.

Laurent Sebbag (L)

Lyon University Hospital, Lyon, France.

Matteo Pozzi (M)

Lyon University Hospital, Lyon, France.

Thibaud Genet (T)

Tours University Hospital, Tours, France.

Thierry Bourguignon (T)

Tours University Hospital, Tours, France.

Anne-Céline Martin (AC)

HEGP, AP-HP, Paris, France.

Paul Achouh (P)

HEGP, AP-HP, Paris, France.

Fabrice Vanhuyse (F)

Nancy University Hospital, Villeneuve les Nancy, France.

Hugues Blangy (H)

Nancy University Hospital, Villeneuve les Nancy, France.

Charles Henri (C)

Institut du Thorax, Nantes University Hospital, nantes, France.

Magali Michel (M)

Institut du Thorax, Nantes University Hospital, nantes, France.

Frédéric Anselme (F)

Rouen University Hospital, Rouen, France.

Pierre-Yves Litzler (PY)

Rouen University Hospital, Rouen, France.

Marie Jungling (M)

Lille University Hospital, Lille, France.

André Vincentelli (A)

Lille University Hospital, Lille, France.

Romain Eschalier (R)

Clermont-Ferrand University Hospital, Clermont-Ferrand, France.

Nicolas D'ostrevy (N)

Clermont-Ferrand University Hospital, Clermont-Ferrand, France.

Patrick Nataf (P)

Bichat University Hospital, AP-HP, Paris, France.

Marylou Para (M)

Bichat University Hospital, AP-HP, Paris, France.

Fabien Garnier (F)

Department of Cardiology, Dijon University Hospital, Dijon, France.

Priyanka Rajinthan (P)

Department of Cardiac Surgery, Dijon University Hospital, Dijon, France.

Jean Porterie (J)

Cardiovascular Surgery department, Toulouse University Hospital, Toulouse, France.

Maxime Faure (M)

Cardiology department, Bordeaux University Hospital, Pessac, France.

François Picard (F)

Cardiology department, Bordeaux University Hospital, Pessac, France.

Philippe Gaudard (P)

Department of anesthesiology and critical care medicine Arnaud de Villeneuve, CHU Montpellier, University of Montpellier, PhyMedExp, INSERN, CNRS, Montpellier, France.

Philippe Rouvière (P)

Department of cardiac surgery, CHU Montpellier, University of Montpellier, Montpellier, France.

Gérard Babatasi (G)

Caen University Hospital, Caen, France.

Katrien Blanchart (K)

Caen University Hospital, Caen, France.

Vlad Gariboldi (V)

Cardiac Surgery Department, La Timone University Hospital, AP-HM, Marseille, France.

Alizée Porto (A)

Cardiac Surgery Department, La Timone University Hospital, AP-HM, Marseille, France.

Erwan Flecher (E)

Cardiac Surgery Department, Rennes University Hospital, Rennes, France.

Clement Delmas (C)

Cardiology Department, Toulouse University Hospital, Toulouse, France; REICATRA, Institut Saint Jacques, CHU de Toulouse, Toulouse, France.

Classifications MeSH